Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
BioSpace
4h
7 Indications for GLP-1s Beyond Weight Loss
Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...
ConsumerAffairs
7h
FDA approves Zepbound as a treatment for obstructive sleep apnea
Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...
Daily
17h
Tirzepatide taken for weight loss may lead to Colonic Ischemia: Case report
A recent case published in the journal ACG CASE REPORTS JOURNAL found a possible risk of colonic ischemia caused by the usage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
MLB's stolen base king dies
US fighter jet shot down
Vows to rename Denali
Taxpayers to get up to $1,400
Drops out of Senate race
Social Security bill approved
China: US ‘playing with fire'
Warns on Panama Canal
'Die Hard 2' actor dies
Ambassador to Switzerland
Miller to join DOGE panel
Top NYPD officer resigns
Proposes contract changes
MO abortion ban blocked
RFK Stadium bill passed
Nic Claxton fined $25K
100 salmonella cases linked
US ambassador to Italy
Russian fuel depot targeted
NBA fines Celtics coach
Brazil bus crash: 38 dead
Special envoy to the UK
Reverses Ohio layoffs
Speeds to $62M debut
Moore receives Bronze Star
Deputy defense secretary
Skiers, snowboarders rescued
Team Langer wins in playoff
Penn State wins eighth title
Starbucks strike expands
Related topics
FDA
Food and Drug Administration
Eli Lilly
Weight loss
Zepbound
Feedback